RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 39 filers reported holding RAIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,495 | +14.7% | 11,028 | +59.9% | 0.00% | – |
| Q2 2023 | $8,275 | -93.8% | 6,896 | -54.5% | 0.00% | – |
| Q1 2023 | $132,560 | +281.8% | 15,167 | +249.5% | 0.00% | – |
| Q4 2022 | $34,720 | -63.8% | 4,340 | -78.0% | 0.00% | – |
| Q3 2022 | $96,000 | -57.0% | 19,716 | -50.9% | 0.00% | – |
| Q2 2022 | $223,000 | -26.2% | 40,184 | -32.6% | 0.00% | – |
| Q1 2022 | $302,000 | -58.9% | 59,591 | +4.4% | 0.00% | – |
| Q4 2021 | $735,000 | +21.7% | 57,085 | +41.4% | 0.00% | – |
| Q3 2021 | $604,000 | +3255.6% | 40,379 | +3442.0% | 0.00% | – |
| Q2 2021 | $18,000 | – | 1,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 2,034,552 | $1,753,377 | 0.54% |
| TANG CAPITAL MANAGEMENT LLC | 3,740,341 | $3,223,426 | 0.46% |
| PVG ASSET MANAGEMENT CORP | 47,520 | $40,952 | 0.28% |
| Acuitas Investments, LLC | 409,256 | $352,697 | 0.21% |
| Ghost Tree Capital, LLC | 325,000 | $280,085 | 0.09% |
| BVF INC/IL | 3,526,729 | $3,039,335 | 0.08% |
| BML Capital Management, LLC | 72,926 | $62,848 | 0.06% |
| Boxer Capital, LLC | 1,152,212 | $992,976 | 0.05% |
| Marquette Asset Management, LLC | 84,135 | $72,508 | 0.02% |
| Shay Capital LLC | 31,730 | $27,345 | 0.00% |